Dx Serology
all the imbecile titles not showing what they intend to test
32031264 2020. Evolving status of the 2019 novel coronavirus infection: Proposal of conventional serologic assays for disease diagnosis and infection monitoring
32343775 ä. SARS-CoV-2 Serology: Much Hype, Little Data
32295707 ä. Fast and simple high-throughput testing of COVID 19
32357206 ä. Role of serology in the COVID-19 pandemic
32286155 2020. Significance of serology testing to assist timely diagnosis of SARS-CoV-2 infections: implication from a family cluster
32326952 2020. SARS-CoV-2 viral load in sputum correlates with risk of COVID-19 progression
32286019 2020. Serological Assays for SARS-CoV-2 Infectious Disease: Benefits, Limitations and Perspectives
32347204 2020. Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020
32327448 2020. Comparison of Abbott ID Now and Abbott m2000 methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from symptomatic patients
32303565 2020. The Detection of SARS-CoV-2 using the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays
32277022 2020. Clinical evaluation of the cobas SARS-CoV-2 test and a diagnostic platform switch during 48 hours in the midst of the COVID-19 pandemic
32294808 2020. The Royal College of Pathologists of Australasia (RCPA) position statement on COVID-19 (serology)
32342927 2020. Diagnostic performance of COVID-19 serology assays
32322891 ä. Double-Edged Spike?Are SARS-CoV-2 Serologic Tests Safe Right Now?
32492760 2020. Diagnostic Performance of a Rapid Point of Care Test for SARS-CoV-2 in an Urban ED Setting.
32311142 2020. Serological tests facilitate identification of asymptomatic SARS-CoV-2 infection in Wuhan, China
32322898 ä. Double-Edged Spike: Are SARS-CoV-2 Serologic Tests Safe Right Now?
32434706 2020. Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2.
32416599 2020. Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG
32366669 2020. Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Test
32504946 2020. Validation and verification of the Abbott RealTime SARS-CoV-2 assay analytical and clinical performance.
32434807 2020. COVID-19 serologic testing: FAQs and caveats.
32430309 2020. Serology for SARS-CoV-2: Apprehensions, opportunities, and the path forward.
32414781 2020. Serology assays to manage COVID-19.
32456766 2020. Are patients with systemic lupus erythematosus more prone to result false-positive for SARS-CoV2 serology?
32500987 2020. Characteristics and assessment of the usefulness of serological tests in the diagnostic of infections caused by coronavirus SARS-CoV-2 on the basis of available manufacturer's data and literature review.
32482633 2020. Clinical performance of the Luminex NxTAG CoV Extended Panel for SARS-CoV-2 detection in nasopharyngeal specimens of COVID-19 patients in Hong Kong.
{{tp|p=32462501|t=2020. The Allplex 2019-nCoV (Seegene) assay: which performances are for SARS-CoV-2 infection diagnosis?|pdf=|usr=0
32503847 2020. Multi-Center Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Assay for the Detection of SARS-CoV-2 in Oropharyngeal Swab Specimens.
32402061 2020. Clinical Performance of Two SARS-CoV-2 Serologic Assays.
32484860 2020. Clinical Performance of the Roche SARS-CoV-2 Serologic Assay.
32445559 2020. Whole nucleocapsid protein of SARS-CoV-2 may cause false positive results in serological assays.
32484942 2020. Potential pitfalls of routine SARS-CoV-2 serology for mass screening.
32391022 2020. Serological Approaches for COVID-19: Epidemiologic Perspective on Surveillance and Control.
32487681 2020. SARS-CoV-2 serology: Test, test, test, but interpret with caution!
32520228 2020. Sensitivity of the Wondfo One Step COVID-19 test using serum samples.
32425657 2020. Evaluation of the COVID19 ID NOW EUA assay.
32417674 2020. Multi-center evaluation of cepheid xpert(R) xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic.
32474036 2020. Qualitative serology in patients recovered from SARS CoV 2 infection.
32474037 2020. Improved sensitivity using a dual target, E and RdRp assay for the diagnosis of SARS-CoV-2 infection: Experience at a large NHS Foundation Trust in the UK.
32143123 2020. Rapid random access detection of the novel SARS-coronavirus-2 (SARS-CoV-2, previously 2019-nCoV) using an open access protocol for the Panther Fusion.
32353760 2020. Comparison of the Panther Fusion and a laboratory-developed test targeting the envelope gene for detection of SARS-CoV-2.
32526675 2020. AusDiagnostics SARS-CoV-2 kits shown to be more sensitive than reference laboratory test.
32516739 2020. Evaluation of the commercially available LightMix(R) Modular E-gene kit using clinical and proficiency testing specimens for SARS-CoV-2 detection.
